| Literature DB >> 26167194 |
Ivana Baralic1, Marija Andjelkovic1, Brizita Djordjevic2, Nenad Dikic1, Nenad Radivojevic1, Violeta Suzin-Zivkovic3, Sanja Radojevic-Skodric4, Snezana Pejic5.
Abstract
The physiologic stress induced by physical activity is reflected in immune system perturbations, oxidative stress, muscle injury, and inflammation. We investigated the effect of astaxanthin (Asx) supplementation on salivary IgA (sIgA) and oxidative stress status in plasma, along with changes in biochemical parameters and total/differential white cell counts. Forty trained male soccer players were randomly assigned to Asx and placebo groups. Asx group was supplemented with 4 mg of Asx. Saliva and blood samples were collected at the baseline and after 90 days of supplementation in preexercise conditions. We observed a rise of sIgA levels at rest after 90 days of Asx supplementation, which was accompanied with a decrease in prooxidant-antioxidant balance. The plasma muscle enzymes levels were reduced significantly by Asx supplementation and by regular training. The increase in neutrophil count and hs-CRP level was found only in placebo group, indicating a significant blunting of the systemic inflammatory response in the subjects taking Asx. This study indicates that Asx supplementation improves sIgA response and attenuates muscle damage, thus preventing inflammation induced by rigorous physical training. Our findings also point that Asx could show significant physiologic modulation in individuals with mucosal immunity impairment or under conditions of increased oxidative stress and inflammation.Entities:
Year: 2015 PMID: 26167194 PMCID: PMC4488551 DOI: 10.1155/2015/783761
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Subject characteristics at baseline.
| Astaxanthin | Placebo | |
|---|---|---|
| Age (year) | 17.9 ± 0.2 | 17.6 ± 0.1 |
| Weight (kg) | 71 ± 1.7 | 72 ± 1.8 |
| Height (cm) | 178 ± 1.4 | 180 ± 1.4 |
| Body mass index (kg/m2) | 22.4 ± 0.3 | 22.2 ± 0.4 |
| Fat (%) | 9.4 ± 0.7 | 9.7 ± 0.8 |
| VO2max (mL/min/kg) | 55.5 ± 1.2 | 52.9 ± 0.7 |
Values are expressed as mean ± SE.
Estimated daily energy and nutrient intake of soccer players.
| Asx | P | |
|---|---|---|
| Energy (kcal) | 3154 ± 247 | 2932 ± 147 |
| Protein (g) | 124 ± 8.7 | 125 ± 6.3 |
| Carbohydrates (g) | 412 ± 33 | 366 ± 23 |
| Monosaccharides (g) | 109 ± 12 | 123 ± 18 |
| Fiber (g) | 13.2 ± 1.4 | 12.6 ± 1.5 |
| Fat (g) | 104 ± 9 | 101 ± 7 |
| Saturated fat (g) | 33.2 ± 3.5 | 29.9 ± 3.2 |
| Cholesterol (mg) | 328 ± 23 | 344 ± 38 |
| Vitamin A (IU) | 2312 ± 442 | 2120 ± 389 |
| Vitamin C (mg) | 149 ± 25 | 135 ± 30 |
| Vitamin E (mg) | 5.4 ± 0.7 | 6.1 ± 1.5 |
| Copper (mg) | 2.3 ± 0.4 | 1.92 ± 0.5 |
| Iron (mg) | 14.4 ± 0.9 | 15.1 ± 1.6 |
| Manganese (mg) | 4.9 ± 0.3 | 4.0 ± 0.9 |
| Selenium ( | 187 ± 15 | 164 ± 8 |
| Zinc (mg) | 13.0 ± 1.4 | 13.5 ± 1.8 |
Values are expressed as mean ± SE.
Figure 1Salivary flow (a), salivary IgA concentration (b), and salivary IgA secretion rate (c) in soccer players at baseline and after 90 days of supplementation. Values are presented as mean ± SE. The difference in relation to baseline was significant at 0.05 (∗).
Oxidative stress status of the soccer players at baseline and after 90 days of supplementation.
| Astaxanthin | Placebo | ANOVA | |||||
|---|---|---|---|---|---|---|---|
| Before supplementation | After supplementation | Before supplementation | After supplementation | T | S | T × S | |
| TAS (mmolTrolox equiv./L) | 0.551 ± 0.036 | 0.538 ± 0.029 | 0.532 ± 0.039 | 0.585 ± 0.031 | ns | ns | ns |
| TOS (mmol/L) | 15.4 ± 1.5 | 5.0 ± 0.5 | 16.8 ± 1.6 | 5.1 ± 0.5 | <0.001 | ns | ns |
| PAB (HK U) | 479.1 ± 45.4 | 291.5 ± 33.3 | 338.9 ± 48.8 | 258.9 ± 35.8 | <0.001 | ns | <0.05 |
Values are expressed as mean ± SE. ANOVA: T-training, S-supplementation, and T × S-training and supplementation interaction effect.
The difference in relation to baseline was significant at p < 0.001 ().
Figure 2Total leukocyte count (denoted by numbers at the top of the bars); neutrophil, lymphocyte, and monocyte counts in soccer players at baseline and after 90 days of supplementation.
Biochemical profile of the soccer players at baseline and after 90 days of supplementation.
| Astaxanthin | Placebo | ANOVA | |||||
|---|---|---|---|---|---|---|---|
| Before supplementation | After supplementation | Before supplementation | After supplementation | T | S | T × S | |
| AST (U/L)† | 37.5 (29.2–48.1) | 23.8 (20.1–28.1) | 41.0 (35.7–47.0) | 28.7 (24.5–33.6) | 0.001 | <0.05 | ns |
| ALT (U/L)† | 21.1 (16.8–25.6) | 18.9 (15.6–21.6) | 20.7 (18.6–22.5) | 19.2 (16.1–22.6) | ns | ns | ns |
| CK (U/L)† | 448 (330–608) | 248 (172–360) | 525 (283–974) | 367 (244–552) | <0.01 | ns | ns |
| LDH (U/L)‡ | 418.3 ± 13.8 | 303.5 ± 10.3 | 441.2 ± 17.5 | 359.4 ± 15.8 | <0.001 | <0.05 | ns |
| UA ( | 330.3 ± 19.1 | 300.4 ± 14.0 | 346.5 ± 20.9 | 315.9 ± 15.5 | <0.05 | ns | ns |
| Cre ( | 129.6 ± 2.1 | 126.5 ± 2.2 | 133.1 ± 2.3 | 130.5 ± 2.4 | <0.05 | ns | ns |
| hs-CRP (mg/L)† | 1.35 (1.00–1.82) | 1.19 (0.89–1.59) | 1.26 (0.89–1.78) | 1.98 (1.24–3.17) | ns | ns | 0.05 |
| CHOL (mmol/L)‡ | 4.28 ± 0.20 | 4.39 ± 0.24 | 4.54 ± 0.28 | 4.50 ± 0.27 | ns | ns | ns |
| HDL-C (mmol/L)‡ | 1.27 ± 0.19 | 1.30 ± 0.05 | 1.29 ± 0.07 | 1.31 ± 0.06 | ns | ns | ns |
| LDL-C (mmol/L)‡ | 2.63 ± 0.19 | 2.73 ± 0.20 | 2.97 ± 0.24 | 2.91 ± 0.25 | ns | ns | ns |
| TG (mmol/L)‡ | 0.84 ± 0.12 | 0.80 ± 0.08 | 0.95 ± 0.14 | 0.70 ± 0.09 | ns | ns | ns |
‡Mean ± SE.; †Geometric mean values (95th confidence interval). ANOVA: T-training, S-supplementation, and T × S-training and supplementation interaction effect. The difference in relation to baseline was significant at p < 0.05 (), p < 0.01 (), and p < 0.001 ().